Utama › Kanser Prostat Rintangan Kastra › New York
Kajian klinikal Kanser Prostat Rintangan Kastra di New York
8 kajian untuk Kanser Prostat Rintangan Kastra sedang mencari peserta di lokasi di New York.
Bandar di New York
Teks kajian rasmi (Bahasa Inggeris)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
- NYU Langone Health Laura and Isaac Perlmutter Cancer Center, New York
- Montefiore Medical Center, The Bronx
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07225946A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- NYU Langone Hospitals, Brooklyn
- NYU Langone Hospital Long Island, Mineola
- NYU Langone Health Laura and Isaac Perlmutter Cancer Center, New York
- dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 25 Sep 2026 · NCT07164443A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- Memorial Sloan Kettering Cancer Center ( Site 0006), New York
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06863272Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Northwell Health R.J. Zuckerberg Cancer Hospital, Lake Success
- NYU Langone Health Long Island, Mineola
- NYU Langone Health, New York
- dan 3 lagi
Mengambil pesertaFasa 1
Umur 18 hingga 100 · Lelaki · Dikemas kini 13 Ogo 2026 · NCT05519449A Study of MGC026 in Participants With Advanced Solid Tumors
- START-New York Long Island, Lake Success
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT06242470A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaFasa 1
Umur 18 ke atas · Lelaki · Dikemas kini 10 Ogo 2026 · NCT0606784164Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
- Weill Cornell Medicine at New York-Presbyterian, New York
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Lelaki · Dikemas kini 6 Mei 2026 · NCT04868604Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer
- Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York
Mengambil pesertaFasa 1
Umur 18 ke atas · Lelaki · Dikemas kini 21 Nov 2025 · NCT05743621Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.